Table 5.
Overview of studies in which a continuous measurement of the pharmacological effect was used together repeated measurement of pharmacokinetics
| Drug | Endpoint |
|---|---|
| Benzodiazepines + related GABA receptor agonists | EEG parameters [29, 60, 66] |
| Cyclopentyl-adenosine A1 receptor agonists | Hemodynamic parameters [31] Biochemical parameters: lipolysis [118] |
| Opioids | EEG effect parameters [119, 120] Anti-nociceptive effect; Respiratory depression [71, 121] |
| 5-HT1A receptor agonists | Body temperature [64, 83] |
| Dopamine D2 receptor agonists | Receptor occupancy [122, 123] Prolactin responses [61] |